Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
95 studies found for:    Open Studies | "Heparin"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)
Condition: Heparin-Induced Thrombocytopenia
Interventions: Other: Scoring 4Ts and Chong scale;   Other: Blood draw
2 Unknown  ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
Conditions: The Primary Study Objective is to Assess the Efficacy and;   Safety of Extended 4-week Heparin Prophylaxis Compared to;   Prophylaxis Given for 8±2 Days After Planned Laparoscopic;   Surgery for Colorectal Cancer.;   The Clinical Benefit Will be Evaluated as the Difference in;   the Incidence of VTE or VTE-related Death Occurring Within 30 Days;   From Surgery in the Two Study Groups.
Intervention: Drug: Heparin, Low-Molecular-Weight
3 Recruiting Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.
Condition: To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come
Interventions: Drug: Low molecular weight heparin;   Drug: Low dose aspirin;   Drug: Heparin & aspirin;   Other: NaCl
4 Recruiting Understanding "Heparin Resistance" in Cardiac Surgery
Conditions: Cardiopulmonary Bypass;   Altered Heparin Response
Interventions: Drug: Heparin;   Drug: ATryn
5 Unknown  Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure
Conditions: Heparin-Induced Thrombocytopenia;   Thrombosis
Intervention:
6 Recruiting Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Intervention: Drug: Rivaroxaban
7 Unknown  Argatroban in Critically Ill Patients With Heparin Resistance
Condition: Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance
Intervention: Drug: Argatroban
8 Unknown  Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients
Condition: Allergy
Intervention:
9 Unknown  Heparin for Pregnant Women With Thrombophilia
Condition: Pregnancy and Thrombophilia
Intervention: Drug: Nadroparin calcium
10 Unknown  Evaluation of Heparin Rebound in Cardiac Surgery
Condition: Coagulation Delay
Intervention:
11 Recruiting Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
Conditions: Obesity;   Morbid Obesity;   Venous Thromboembolism;   Atrial Fibrillation;   Angina;   Chest Pain
Intervention: Drug: Lean Body Weight-based heparin dose
12 Recruiting Aspirin, Heparin and Miscarriage
Conditions: Pregnancy;   Miscarriage
Interventions: Drug: Aspirin;   Drug: Heparin
13 Recruiting Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation
Condition: Coagulation; Intravascular
Interventions: Drug: Continuous heparin infusion;   Drug: Intermittent heparin infusion
14 Recruiting Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
Conditions: Acute Chest Syndrome;   Sickle Cell Disease
Intervention: Drug: Unfractionated heparin
15 Unknown  DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
Conditions: Stable Angina;   Angina, Unstable;   Non-ST Elevation (NSTEMI) Myocardial Infarction
Interventions: Drug: Low-dose heparin;   Drug: Standard dose heparin
16 Recruiting Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
Condition: Acute Ischemic Stroke
Interventions: Drug: Heparin;   Drug: Nadroparin;   Drug: Placebo
17 Unknown  Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI
Condition: Coronary Artery Disease
Intervention: Procedure: Percutaneous Coronary Intervention (PCI)
18 Recruiting Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
Conditions: Inhalation Injury;   Burn Injury
Interventions: Drug: unfractionated heparin;   Drug: placebo
19 Unknown  Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Condition: Cardiac Surgery
Interventions: Drug: heparin sodium - Bergamo;   Drug: heparin sodium - APP
20 Unknown  Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years